Process used in drug discovery to identify and block specific enzymes, for example in harmful bacteria.

The process involves finding substances (inhibitors) that can attach well to certain enzymes in harmful bacteria, affect their whole-cell activity, and disrupt their functions without causing undue harm to the host organism. The blocking action hinders the bacteria’s ability to function or cause harm, leading to potential new treatments for infectious diseases.